EDMONTON, Alberta, April 11 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that it has received regulatory approval of its VScan Dengue Fever test kit in Saudi Arabia. Currently there is an outbreak of Dengue Fever in the Middle East. There are 4 different strains of Dengue Fever. The VScan Dengue Fever test kit has the ability to detect all 4 different strains. This is important in that infection with one strain does not give immunity from the 3 other strains. Dengue Fever is transmitted by mosquitoes. In its mildest form Dengue Fever can incapacitate an individual for up to 6 months. In the worst case, the individual dies within days through massive hemorrhaging. Successful treatment of Dengue Fever depends on early detection. The standard laboratory takes a minimum of three (3) days to as long as twenty-one (21) days to complete a test for Dengue Fever. The VScan Dengue Fever test kit gives results in less than 15 minutes and is accurate greater than 99% of the time. The Company believes that the regulatory approval by Saudi Arabia of the Dengue Fever test kit should increase the anticipated sales of the Dengue Fever Kit from 400,000 to 750,000 kits. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/

Copyright